FDA OKs New Drug Saphris for Schizophrenia, Bipolar I Disorder
FDA OKs New Schizophrenia, Bipolar Drug Saphris Trumps Placebo at Reducing Symptoms of Schizophrenia, Bipolar Disorder WebMD Medical News By Miranda Hitti Reviewed by Louise Chang, MD More from WebMD...
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.